Skip to main content
Year archive

CYCLOPHARM LIMITED — 2022 filings

All 33 regulatory filings released by CYCLOPHARM LIMITED (CYC) in 2022, sourced directly from the official regulator.

33 Filings
2022 Period
2022 filings (33)
Filing Released Lang
Change of Director's Interest Notice - KBarrow 2 pages 206.5KB
Director's Dealing
2022-12-04 English
Change of Director's Interest Notice - DAngus 2 pages 206.2KB
Director's Dealing
2022-11-29 English
Cyclopharm Receives $1.64m R&D Refund 2 pages 143.9KB
Capital/Financing Update
2022-11-28 English
Bell Potter Healthcare Conference 18 pages 2.6MB
Investor Presentation
2022-11-08 English
Bell Potter Healthcare Conference Directors Profile 18 pages 2.6MB
Investor Presentation
2022-11-08 English
Notification of cessation of securities - CYC 4 pages 24.1KB
Share Issue/Capital Change
2022-10-04 English
Initial Director's Interest Notice 2 pages 123.1KB
Director's Dealing
2022-09-26 English
CYC Board Changes 2 pages 160.8KB
Board/Management Information
2022-09-26 English
CYC Board Changes 2 pages 158.5KB
Board/Management Information
2022-08-31 English
Initial Director's Interest Notice 2 pages 123.4KB
Director's Dealing
2022-08-31 English
Dividend/Distribution - CYC 4 pages 24.9KB
Notice of Dividend Amount
2022-08-16 English
Half Yearly Report and Accounts 33 pages 1.5MB
Interim / Quarterly Report
2022-08-16 English
Half Year 2022 Results 4 pages 280.2KB
Interim / Quarterly Report
2022-08-16 English
Technegas Used In Multicenter COVID Study 2 pages 181.6KB
Regulatory Filings
2022-07-06 English
1H 2022 Business Update - Record Revenues 4 pages 176.6KB
Management Reports
2022-07-03 English
Change of Director's Interest Notice 2 pages 206.4KB
Director's Dealing
2022-06-13 English
Technegas used in Diagnosing Long COVID 3 pages 214.0KB
Regulatory Filings
2022-05-23 English
CYC Investor Presentation 24 May 2022 35 pages 5.8MB
Investor Presentation
2022-05-23 English
Change of Director's Interest Notice 2 pages 206.4KB
Director's Dealing
2022-05-22 English
Chairman's Address to Shareholders 4 pages 204.0KB
AGM Information
2022-05-16 English
CYC 2022 AGM Presentation 31 pages 2.5MB
AGM Information
2022-05-16 English
Managing Director's Address to Shareholders 6 pages 231.3KB
Investor Presentation
2022-05-16 English
Results of Meeting 2 pages 141.9KB
Declaration of Voting Results & Voting Rights Announcements
2022-05-16 English
Notice of Annual General Meeting/Proxy Form 13 pages 823.3KB
AGM Information
2022-04-13 English
Annual Report to shareholders 84 pages 1.8MB
Annual Report
2022-03-30 English
Appendix 4G 22 pages 391.5KB
Regulatory Filings
2022-03-30 English
Date of Annual General Meeting 1 page 77.8KB
AGM Information
2022-03-15 English
Change of Director's Interest Notice 2 pages 205.9KB
Director's Dealing
2022-03-08 English
Preliminary Final Report 69 pages 539.5KB
Annual Report
2022-02-22 English
Dividend/Distribution - CYC 4 pages 25.0KB
Notice of Dividend Amount
2022-02-22 English
CYC Results Summary 4 pages 158.7KB
Earnings Release
2022-02-22 English
Cyclopharm USFDA Update 2 pages 130.1KB
Regulatory Filings
2022-02-02 English
Cyclopharm Business Update 4 pages 172.1KB
Capital/Financing Update
2022-01-23 English